title: [Should cost benefit analysis be done when new routines are introduced?].
authors.affiliation: Infektionskliniken, regionsjukhuset, Orebro.
authors.forename: E
authors.initials: E
authors.lastname: Bäck
mesh_terms: D001782:Blood Donors; D003362:Cost-Benefit Analysis; D006508:Hepatitis Antibodies / Q000032:analysis; D006526:Hepatitis C / Q000191:economics / Q000517:prevention & control / Q000635:transmission*; D006801:Humans
chemical_list: D006508:Hepatitis Antibodies
vernacular_title: Skall vi göra kostnad-nyttabedömningar vid införandet av nya rutiner?